10-Q: Pyxus Reports Q1 Loss Amid Revenue Decline

Sentiment:

Quarterly Report


Pyxus International, Inc. reported a net loss of $15.8 million for the quarter ended June 30, 2025, a significant decline from the prior year's profit, driven by lower sales volumes.

Capital raiseThe company continues to finance its business with a combination of short-term and long-term credit lines, long-term debt securities, advances from customers, and cash from operations.The ABL Credit Facility was amended to increase the aggregate amount of revolving loan commitments to $150.0 million and extend its maturity to May 12, 2030.The total borrowing capacity under foreign seasonal lines of credit increased by $209.6 million to $1,025.2 million, primarily utilized to purchase larger volumes of green tobacco.Management stated that they continuously monitor and adjust funding sources and may undertake actions to reduce debt or improve financial position, including prepayments, open market debt repurchases, negotiated repurchases, other redemptions or retirements of outstanding debt, and refinancing of debt.
Worse than expectedNet income shifted to a net loss of $15.8 million for the quarter, compared to a $4.6 million profit in the prior year.Sales and other operating revenues decreased by 19.9% to $508.8 million.Operating income declined by 48.1% to $21.0 million.Net cash used in operating activities significantly increased to $495.3 million from $252.2 million.Working capital declined by 15.0% to $374.2 million, and the current ratio decreased from 1.4 to 1 to 1.3 to 1.

Summary

  • Net loss attributable to Pyxus International, Inc. was $15.8 million for the three months ended June 30, 2025, compared to net income of $4.6 million for the same period in 2024.
  • Sales and other operating revenues decreased by 19.9% to $508.8 million for the quarter, down from $634.9 million in the prior year.
  • The decline in sales was primarily due to a 30.1% decrease in kilo volumes sold, mainly from Africa and North America, resulting from the acceleration of certain customer shipments into the fourth quarter of fiscal year 2025.
  • Gross profit decreased by 21.8% to $65.6 million, with gross profit as a percent of sales slightly declining to 12.9% from 13.2%.
  • Operating income fell by 48.1% to $21.0 million.
  • Net cash used in operating activities significantly increased to $495.3 million, up from $252.2 million in the prior year, primarily to fund purchases of larger crops.
  • Total tobacco inventory increased to $1,089.8 million at June 30, 2025, positioning the company to meet customer demand.
  • Working capital declined by 15.0% to $374.2 million as of June 30, 2025, driven by higher borrowings on foreign seasonal lines of credit.
  • The ABL Credit Facility was amended to increase revolving loan commitments to $150.0 million and extend its maturity to May 12, 2030.
  • Total borrowing capacity under foreign seasonal lines of credit increased by $209.6 million to $1,025.2 million, primarily utilized for green tobacco purchases.

Sentiment

Score: 4

Explanation: The financial results for the quarter are significantly negative, marked by a shift to a net loss and substantial declines in revenue and operating income. While the company highlights operational successes in securing larger crop volumes and managing debt, the immediate financial performance is concerning. The increased cash usage in operations and decline in working capital indicate liquidity pressures, despite increased borrowing capacity. The positive outlook on future crop supply provides some offset, but the current quarter's performance is a clear setback.

Positives

  • Successfully secured necessary funds to purchase larger volumes of green tobacco due to a strengthened credit profile.
  • Favorable weather conditions in the Southern Hemisphere (Africa and South America) led to larger volumes of better quality leaf for the fiscal year 2026 crop.
  • Processing and other revenues increased by 20.1% to $50.2 million, with processing and other gross profit increasing by 72.7% to $7.6 million.
  • Average price per kilo for leaf tobacco increased by 11.2% to $6.85.
  • Interest expense, net, decreased by 10.5% to $29.8 million.
  • Completed repurchases of 2027 Notes and Pyxus Term Loans from affiliated funds at a discount to par value, reducing future debt obligations.
  • Cash and cash equivalents increased to $96.4 million from $82.0 million in the prior year period.
  • The ABL Credit Facility's aggregate revolving loan commitments were increased to $150.0 million and its maturity extended to May 12, 2030.

Negatives

  • Shifted from a net income of $4.6 million in the prior year to a net loss of $15.8 million.
  • Sales and other operating revenues decreased by 19.9% due to lower kilo volumes sold.
  • Operating income declined significantly by 48.1%.
  • Net cash used in operating activities more than doubled to $495.3 million.
  • Working capital decreased by 15.0% to $374.2 million.
  • Current ratio declined to 1.3 to 1 from 1.4 to 1 in the prior year.
  • Net debt increased to $1,239.6 million from $1,149.3 million in the prior year.
  • The company faces a material risk from a Brazilian tax assessment of $10.4 million, including penalties and interest, which is being contested.

Risks

  • Reliance on a small number of significant customers and continued vertical integration by customers.
  • Global shifts in sourcing customer requirements, imposition of tariffs, and changes in international trade policies.
  • Shifts in global supply and demand for tobacco products.
  • Variation in financial results due to growing conditions, customer indications, and other factors.
  • Loss of confidence from customers, farmers, and other suppliers.
  • Migration of tobacco suppliers to growing other crops.
  • Risks related to advancing inputs to tobacco suppliers, to be settled upon delivery of unprocessed tobacco.
  • Risk that purchased tobacco may not meet customer quality and quantity requirements.
  • Weather and other environmental conditions affecting inventory quantity and marketability.
  • International business risks, including unsettled political conditions, enforcement of legal obligations, fraud, expropriation, import/export restrictions, exchange controls, inflationary economies, currency risks, and restrictions on repatriation of earnings.
  • Operations in jurisdictions with high risk of Foreign Corrupt Practices Act violations.
  • Risks and uncertainties related to geopolitical conflicts, including the Middle East and shipping disruptions.
  • Impacts of international sanctions on ability to sell or source tobacco.
  • Exposure to foreign tax regimes with unclear or inconsistently applied rules subject to sudden change.
  • Fluctuations in foreign currency exchange and interest rates.
  • Competition with other global independent leaf tobacco merchants.
  • Disruption, failure, or security breaches of information technology systems and other cybersecurity risks.
  • Continued high inflation.
  • Regulations regarding environmental matters.
  • Risks related to capital structure, including significant debt and ability to finance non-U.S. local operations with uncommitted short-term operating credit lines.
  • Ability to continue to access capital markets for financing.
  • Potential failure of foreign banks where subsidiaries maintain deposits or failure to transfer funds/honor withdrawals.
  • Inability to generate significant cash required to service indebtedness.
  • Ability to refinance current credit facilities at same availability or similar/reduced interest rates.
  • Failure to achieve stated goals, potentially adversely affecting liquidity.
  • Volatility and disruption of global credit markets.
  • Failure by counterparties to derivative transactions to perform obligations.
  • Increasing scrutiny and changing expectations from governments and stakeholders regarding environmental, social, and governance policies.
  • Inherent risk of exposure to product liability claims, regulatory action, and litigation for e-liquids business.
  • Certain shareholders' ability to exercise controlling influence on corporate matters.
  • Reductions in demand for consumer tobacco products.
  • Risks and uncertainties related to pandemics or other widespread health crises and related shipping constraints, labor shortages, and supply-chain impacts.
  • Legislative and regulatory initiatives that may reduce consumption of consumer tobacco products, demand for services, and increase regulatory burdens.
  • Government actions significantly affecting tobacco sourcing, including crop diversification initiatives.
  • Governmental investigations into business activities, including leaf tobacco industry buying and payment practices.
  • Impact of proposed regulations to prohibit sale of cigarettes and certain other tobacco products in the United States other than low-nicotine versions.

Future Outlook

Management anticipates periods during which liquidity needs for operations will approach the levels of available cash and permitted borrowings. The company may undertake plans to minimize cash outflows, including exiting operations that do not generate positive cash flow, if a liquidity deficiency arises. The larger tobacco crops experienced in Africa and South America are anticipated to provide a more balanced global tobacco market position. The company expects to incur an additional $21.8 million in capital expenditures for the remainder of the fiscal year ending March 31, 2026, and $3.4 million in pension and postretirement contributions.

Management Comments

  • The start to fiscal year 2026 delivered a larger tobacco crop than we experienced in the prior year, and we are pleased with our ability to capture larger quantities of leaf in key markets.
  • First quarter results were below the same period of the prior year as a result of the acceleration of certain customer shipments into the fourth quarter of fiscal year 2025.
  • Our strengthened credit profile enabled us to secure the necessary funds to purchase these larger volumes of green tobacco to satisfy demand from our customers.
  • Our total tobacco inventory balance puts us in the position to meet the needs of our customers.

Industry Context

The company operates in the global agricultural sector, specifically within the tobacco leaf business, which is characterized by seasonality and susceptibility to weather conditions affecting crop size and quality. The filing indicates that while undersupply conditions have persisted in the global tobacco market recently, larger crops in Africa and South America are expected to lead to a more balanced market position. The industry also faces increasing scrutiny regarding environmental, social, and governance policies, and potential legislative and regulatory initiatives aimed at reducing tobacco consumption.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results to assess performance against global benchmarks. The company's performance is discussed in relation to its own prior periods and general market conditions (e.g., global tobacco market undersupply).

Legal Proceedings

  • A tax assessment in the Brazilian State of Parana for $10.4 million (including penalties and interest) related to local intrastate trade tax credits, which the company is contesting. A loss in this judicial process could have a material impact.
  • Involvement in other litigation or legal matters incidental to business activities, including tax matters, which are being vigorously defended. While outcomes are uncertain, the company does not currently expect a material adverse effect, but a resolution adverse to expectations could be material.

Related Party Transactions

  • Engages in transactions with equity method investees for procuring and processing inventory, with sales of $9.1 million and purchases of $27.3 million for the quarter.
  • Accounts receivable from related parties totaled $1.5 million, and accounts payable to related parties totaled $18.3 million as of June 30, 2025.
  • Advances from related parties totaled $5.9 million as of June 30, 2025.
  • Significant shareholders (Glendon Capital Management, Monarch Alternative Capital, Owl Creek Asset Management) are holders of the Intabex Term Loans, Pyxus Term Loans, and 2027 Notes.
  • Completed debt repurchases from funds affiliated with Monarch Alternative Capital LP at a discount: $77.9 million of 2027 Notes for $62.3 million (including fees/interest) on March 28, 2024; $10.3 million of Pyxus Term Loans for $9.4 million (including interest) on May 31, 2024; and $34.2 million of 2027 Notes for $26.7 million (including interest) on August 2, 2024.
  • Repurchased 392,000 shares of common stock for approximately $1.0 million from CI Investments, Inc., a former beneficial owner of more than five percent of common stock.
  • Accrued interest payable to Investor-Affiliated Funds and CI Investments was $1.5 million as of June 30, 2025.
  • Interest expense related to Investor-Affiliated Funds and CI Investments was $5.5 million for the three months ended June 30, 2025.

Stakeholder Impact

  • **Shareholders**: Experienced a net loss and decline in earnings per share, potentially impacting share value. Dividends remain restricted by debt agreements. Share repurchase program is limited.
  • **Creditors**: The company increased its borrowing capacity and successfully repurchased some debt at a discount, indicating active debt management. However, net debt increased, and working capital declined, suggesting ongoing reliance on financing.
  • **Employees**: Equity-based compensation expense was recognized, and unrecognized compensation cost remains for restricted stock units. No management changes were reported.
  • **Customers**: The company's increased inventory of green tobacco positions it to meet customer demand, which is positive for customer relationships and supply reliability.
  • **Suppliers (Farmers)**: The company's ability to secure funds for larger crop purchases benefits tobacco suppliers, particularly in regions with favorable growing conditions.

Next Steps

  • Evaluate the impact of the One Big Beautiful Bill Act of 2025 (OBBBA) on condensed consolidated financial statements for the fiscal year ending March 31, 2026.
  • Continue to monitor and hedge foreign currency costs as needed.
  • Incur an additional $21.8 million in capital expenditures for the remainder of the fiscal year ending March 31, 2026.
  • Make expected cash contributions of $3.4 million to pension and postretirement health and life insurance benefits for the remainder of the fiscal year.
  • Continue to contest the Brazilian tax assessment through the judicial process.
  • Potentially undertake plans to minimize cash outflows, including exiting operations that do not generate positive cash flow, if a liquidity deficiency arises.
  • Consider further share repurchases if current restrictions under applicable debt agreements are modified to permit them, with the program expiring on August 15, 2027.

Key Dates

DateDescription
2007-10-26Brazilian State of Parana issued a tax assessment regarding intrastate trade tax credits.
2020-08-24Indenture for 10.0% Senior Secured First Lien Notes due 2024 (2024 Notes) was dated.
2022-02-08ABL Credit Agreement was entered into by Pyxus Holdings, Inc. and subsidiaries.
2023-02-06Pyxus Holdings entered into the Intabex Term Loan Credit Agreement and Pyxus Term Loan Credit Agreement. Also, 8.5% Senior Secured Notes due 2027 (2027 Notes) were issued.
2023-11-01FASB issued ASU No. 2023-07, Segment Reporting: Improvements to Reportable Segment Disclosures.
2023-12-01FASB issued ASU No. 2023-09, Income Taxes: Improvements to Income Tax Disclosures.
2024-03-21Pyxus Holdings entered into the Debt Repurchase Agreement with funds affiliated with Monarch Alternative Capital LP.
2024-03-25Schedule 13D/A filed by Monarch Alternative Capital LP, reporting beneficial ownership.
2024-03-28Completion of the purchase of $77,922 aggregate principal amount of 2027 Notes from Monarch Investor affiliates.
2024-04-12Pyxus Holdings exercised its rights to complete additional repurchases under the Debt Repurchase Agreement by September 30, 2024.
2024-05-10Modification of outstanding awards under the Incentive Plan, leading to a cumulative catch-up adjustment for equity-based compensation.
2024-05-31Completion of the purchase of $10,345 aggregate principal amount of Pyxus Term Loans from Monarch Investor affiliates.
2024-06-13Schedule 13D/A filed by Glendon Capital Management, L.P., reporting beneficial ownership.
2024-08-02Completion of the purchase of $34,191 aggregate principal amount of 2027 Notes from Monarch Investor affiliates.
2024-08-15Board of Directors authorized a share repurchase program of up to $10 million.
2024-08-21Company entered into a privately negotiated transaction with CI Investments, Inc. to repurchase 392,000 shares of common stock for approximately $1.0 million.
2024-08-22Completion of the share repurchase transaction with CI Investments, Inc.
2024-08-26Maturity and retirement of the 2024 Notes by paying $20,442, including accrued interest.
2024-08-31Owl Creek Asset Management, L.P. reported beneficial ownership of 3,865,000 shares of common stock.
2024-09-03Schedule 13G/A filed by Owl Creek Asset Management, L.P., reporting beneficial ownership.
2024-11-01FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses.
2025-03-31End of fiscal year for which the company's Annual Report on Form 10-K was filed on June 10, 2025.
2025-04-01Interim period disclosure requirements for ASU 2023-07 adopted.
2025-05-12ABL Credit Agreement amended to increase revolving loan commitments and extend maturity.
2025-06-30End of the current quarterly period for this 10-Q filing.
2025-07-04U.S. government enacted the One Big Beautiful Bill Act of 2025 (OBBBA).
2025-07-31Registrant had 24,607,791 shares of Common Stock outstanding.
2025-08-06Date of signing for the Quarterly Report on Form 10-Q.
2025-08-14Restricted stock units for certain non-employee directors are subject to continued board service until this date.
2025-08-15Share repurchase program expires.
2026-03-31Fiscal year end for which certain provisions of OBBBA are effective and for which additional capital expenditures are expected.
2027-03-31Restricted stock units for certain employees are earned ratably until this date.
2027-12-31Maturity date for Intabex Term Loans, Pyxus Term Loans, and 2027 Notes.
2028-04-01Interim period disclosure requirements for ASU 2024-03 are effective.
2030-05-12Extended maturity date for the ABL Credit Facility.
2031-03-31Restricted stock units vest by this date or earlier upon a change-in-control or liquidity event.

Recommendation

hold

The company reported a significant net loss and substantial declines in revenue and operating income, which are strong negative indicators. However, the decline in sales was attributed to timing shifts rather than a fundamental loss of demand, and the company successfully secured financing for larger crop purchases, indicating operational strength in securing future supply. Active debt management, including repurchases at a discount and extension of credit facilities, also shows proactive financial stewardship. Given the mixed signals – poor current financial performance but strategic operational and financial moves to position for future demand – a 'hold' recommendation is appropriate for existing investors to observe if the operational positives translate into improved financial results in subsequent quarters. New investors might also consider a 'hold' as the company navigates a challenging period with strategic adjustments.

Keywords

Tobacco, Leaf tobacco, Agricultural company, SEC filing, 10-Q, Financial results, Quarterly report, Debt management, Liquidity, Supply chain, Crop production, International trade, Risk factors, SEC, Pyxus

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.